Majbritt Jeppesen
Head And Neck Surgery
Arhus, Denmark
Arhus, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Elexacaftor/tezacaftor/ivacaftor is safe and effectively reduces sino-nasal symptoms in people with cystic fibrosis post lung transplantation.
Journal: Respiratory medicine
Published: October 30, 2025
CFTR knock-out mice exhibit impaired renal compensation to dietary NaCl depletion.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: October 14, 2025
Elexacaftor/tezacaftor/ivacaftor corrects salt-wasting in cystic fibrosis.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: October 14, 2025
Treatment outcomes of nontuberculous mycobacterial infection in the Danish Cystic Fibrosis Cohort 2012-23.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: July 28, 2025
Management of Cystic Fibrosis-Related Diabetes in Denmark-A Population-Based, Cross-Sectional Study.
Management of Cystic Fibrosis-Related Diabetes in Denmark-A Population-Based, Cross-Sectional Study.
Journal: Pediatric pulmonology
Published: April 30, 2025
Bone health after 3 years of ETI therapy: a real-world study from the Danish cystic fibrosis cohort.
Bone health after 3 years of ETI therapy: a real-world study from the Danish cystic fibrosis cohort.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: April 25, 2025
Body mass, linear growth, and body composition before and after the introduction of elexacaftor/tezacaftor/ivacaftor among children and adults with cystic fibrosis.
Journal: Clinical nutrition (Edinburgh, Scotland)
Published: April 23, 2025
Severe hepatotoxicity is uncommon following the introduction of Elexacaftor/Tezacaftor/Ivacaftor: A real-world two-years follow-up study of the Danish cystic fibrosis cohort.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: April 03, 2025
Change in pulmonary pathogens 3 years after elexacaftor/tezacaftor/ivacaftor: an observational study in the Danish cystic fibrosis cohort.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: January 31, 2025
The challenged urine bicarbonate excretion test in cystic fibrosis: A comprehensive analysis of urine acid/base parameters.
Journal: Acta physiologica (Oxford, England)
Published: March 19, 2024
Last Updated: 09/26/2026